Backed by GV and Arch Venture Partners, Pelage Pharmaceuticals is advancing a first-of-its-kind topical gel designed to ...

LTR Pharma's (ASX:LTP) nasal spray ED treatment tackles a high unmet need in a unique way, addressing speed of use and ...

Known for its nasal spray offering rapid onset to treat ED, LTR Pharma is expanding its portfolio while aiming for a swift ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

In a setback for Sarepta Therapeutics, a New York panel has voted unanimously to recommend the state Medicaid program pause ...

In a closely watched case, Roche suffered a setback as a court said it would permit a generic version of its rare disease ...

Two people in Louisiana were hospitalized after getting Botox injections from unlicensed sources. Health officials say only ...

A 2013 study used data from two studies to compare sildenafil in 50mg and 100mg doses. Men with ED were given the 50mg sildenafil dose to be taken as needed before intimacy. After two weeks, those ...

They seem to know it better than me.” In the slipperiest, saddest, most surreal episode of the year’s most upsetting ...

The research showed that semaglutide drugs, known as GLP-1 agonists, slow the speed at which alcohol enters the bloodstream.

A one-time experimental treatment shows unprecedented success in slowing Huntington's disease, according to UCL researchers.

A company that bills itself as Australia’s largest provider of erectile dysfunction treatments has encouraged its customers ...